Medicare Enrolled
Dr. Lauren Rome, M.D.
Pulmonary Disease · Wynnewood, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rome from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rome?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rome
Dr. Lauren Rome is a pulmonary disease specialist in Wynnewood, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rome performed 2,113 Medicare services across 1,587 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rome received a total of $10,566 from 45 pharmaceutical and/or device companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rome is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in PA
$10,566 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,113
Medicare services
Top 8% in PA for pulmonary disease
1,587
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
739 | $102 | $170 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
401 | $22 | $80 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
229 | $179 | $325 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
125 | $144 | $270 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
124 | $142 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
107 | $66 | $95 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
92 | $100 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $134 | $240 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
72 | $36 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $71 | $120 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
29 | $16 | $20 |
| New patient office visit, complex (60-74 min) | 20 | $176 | $325 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
20 | $39 | $150 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
17 | $15 | $30 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
15 | $30 | $45 |
| Sleep study with technician monitoring A sleep study that monitors heart rate and breathing while being attended by a technician. |
14 | $45 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,566
Total received (2018-2024)
Avg $1,509/year across 7 years
Top 18% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,530 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$863
2023
$1,145
2022
$1,349
2021
$1,603
2020
$1,256
2019
$2,461
2018
$1,889
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$216
Mylan Specialty L.P.
$169
GlaxoSmithKline, LLC.
$98
Amgen Inc.
$76
Regeneron Healthcare Solutions, Inc.
$62
Electromed, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
GENZYME CORPORATION
$28
Genentech USA, Inc.
$27
United Therapeutics Corporation
$24
HARMONY BIOSCIENCES LLC
$24
PFIZER INC.
$23
Philips North America LLC
$15
INOGEN, INC.
$13
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,630
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,397
GlaxoSmithKline, LLC.
$1,093
Janssen Pharmaceuticals, Inc
$870
Mylan Specialty L.P.
$784
Philips Electronics North America Corporation
$631
Regeneron Healthcare Solutions, Inc.
$524
Insmed, Inc.
$320
Genentech USA, Inc.
$225
Grifols USA, LLC
$193
GENZYME CORPORATION
$141
Amgen Inc.
$133
Respicardia, Inc.
$132
Jazz Pharmaceuticals Inc.
$129
Electromed, Inc.
$118
Actelion Pharmaceuticals US, Inc.
$109
CSL Behring
$87
Novartis Pharmaceuticals Corporation
$79
United Therapeutics Corporation
$76
Allergan Inc.
$72
Baxter Healthcare
$69
Mallinckrodt LLC
$56
Mallinckrodt Hospital Products Inc.
$52
Mallinckrodt Enterprises LLC
$48
Alexion Pharmaceuticals, Inc.
$48
JAZZ PHARMACEUTICALS INC.
$47
Harmony Biosciences LLC
$41
Sunovion Pharmaceuticals Inc.
$39
Resmed Corp
$38
PFIZER INC.
$37
ABBVIE INC.
$34
Shire North American Group Inc
$32
Circassia Pharmaceuticals Inc
$30
Pulmonx Corporation
$29
AtriCure, Inc.
$28
PORTOLA PHARMACEUTICALS, INC.
$26
Advanced Respiratory, Inc
$25
HARMONY BIOSCIENCES LLC
$24
Inogen, Inc.
$21
Paratek Pharmaceuticals, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$20
AbbVie Inc.
$19
Philips North America LLC
$15
Teva Pharmaceuticals USA, Inc.
$14
INOGEN, INC.
$13
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · ATRICURE CRYOSURGICAL SYSTEM · AVYCAZ · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Kcentra · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · POMPE - DISEASE · Prolastin-C · Prolastin-C Liquid · S&RC Und · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · Trilogy 100 · ULTOMIRIS · Utibron · WAKIX · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
264
Per 100K population
30.7
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rome is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 18% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rome experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rome performed 739 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rome receive payments from pharmaceutical companies?
Yes. Dr. Rome received a total of $10,566 from 45 companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rome's costs compare to other pulmonary diseases in Wynnewood?
Dr. Rome's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rome) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Wynnewood
Browse pulmonary diseases in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology